Promising New Treatments for Psoriasis
Psoriasis is a chronic, proliferative, and inflammatory skin disease affecting 2-3% of the population and is characterized by red plaques with white scales. Psoriasis is a disease that can affect many aspects of professional and social life. Currently, several treatments are available to help contro...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2013/980419 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559756905021440 |
|---|---|
| author | Sarah Dubois Declercq Roxane Pouliot |
| author_facet | Sarah Dubois Declercq Roxane Pouliot |
| author_sort | Sarah Dubois Declercq |
| collection | DOAJ |
| description | Psoriasis is a chronic, proliferative, and inflammatory skin disease affecting 2-3% of the population and is characterized by red plaques with white scales. Psoriasis is a disease that can affect many aspects of professional and social life. Currently, several treatments are available to help control psoriasis such as methotrexate, ciclosporin, and oral retinoids. However, the available treatments are only able to relieve the symptoms and lives of individuals. The discovery of new immunological factors and a better understanding of psoriasis have turned to the use of immunological pathways and could develop new biological drugs against specific immunological elements that cause psoriasis. Biological drugs are less toxic to the body and more effective than traditional therapies. Thus, they should improve the quality of life of patients with psoriasis. This review describes new psoriasis treatments, which are on the market or currently in clinical trials that are being used to treat moderate-to-severe plaque psoriasis. In addition, this paper describes the characteristics and mechanisms in detail. In general, biological drugs are well tolerated and appear to be an effective alternative to conventional therapies. However, their effectiveness and long-term side effects need to be further researched. |
| format | Article |
| id | doaj-art-3c18672cf3d04c3181d45778a65a8f70 |
| institution | Kabale University |
| issn | 1537-744X |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-3c18672cf3d04c3181d45778a65a8f702025-02-03T01:29:16ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/980419980419Promising New Treatments for PsoriasisSarah Dubois Declercq0Roxane Pouliot1Centre LOEX de l'Université Laval, Génie Tissulaire et Régénération, LOEX-Centre de Recherche FRSQ du CHU, Aile-R, 1401 18e rue, Québec, QC, G1J 1Z4, CanadaCentre LOEX de l'Université Laval, Génie Tissulaire et Régénération, LOEX-Centre de Recherche FRSQ du CHU, Aile-R, 1401 18e rue, Québec, QC, G1J 1Z4, CanadaPsoriasis is a chronic, proliferative, and inflammatory skin disease affecting 2-3% of the population and is characterized by red plaques with white scales. Psoriasis is a disease that can affect many aspects of professional and social life. Currently, several treatments are available to help control psoriasis such as methotrexate, ciclosporin, and oral retinoids. However, the available treatments are only able to relieve the symptoms and lives of individuals. The discovery of new immunological factors and a better understanding of psoriasis have turned to the use of immunological pathways and could develop new biological drugs against specific immunological elements that cause psoriasis. Biological drugs are less toxic to the body and more effective than traditional therapies. Thus, they should improve the quality of life of patients with psoriasis. This review describes new psoriasis treatments, which are on the market or currently in clinical trials that are being used to treat moderate-to-severe plaque psoriasis. In addition, this paper describes the characteristics and mechanisms in detail. In general, biological drugs are well tolerated and appear to be an effective alternative to conventional therapies. However, their effectiveness and long-term side effects need to be further researched.http://dx.doi.org/10.1155/2013/980419 |
| spellingShingle | Sarah Dubois Declercq Roxane Pouliot Promising New Treatments for Psoriasis The Scientific World Journal |
| title | Promising New Treatments for Psoriasis |
| title_full | Promising New Treatments for Psoriasis |
| title_fullStr | Promising New Treatments for Psoriasis |
| title_full_unstemmed | Promising New Treatments for Psoriasis |
| title_short | Promising New Treatments for Psoriasis |
| title_sort | promising new treatments for psoriasis |
| url | http://dx.doi.org/10.1155/2013/980419 |
| work_keys_str_mv | AT sarahduboisdeclercq promisingnewtreatmentsforpsoriasis AT roxanepouliot promisingnewtreatmentsforpsoriasis |